SUPN – supernus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
12/19
10:09 am
supn
Low
Supernus Pharmaceuticals (NASDAQ:SUPN) had its price target raised by analysts at Stifel Nicolaus from $50.00 to $55.00. They now have a "hold" rating on the stock.
12/19
07:06 am
supn
Medium
Strong Results Lifted Supernus Pharmaceuticals (SUPN) in Q3 [Yahoo! Finance]
12/16
12:23 am
supn
Low
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back [Yahoo! Finance]
12/10
07:18 am
supn
Low
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/9
07:00 am
supn
Medium
Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada
11/4/2025
04:01 pm
supn
-17.4%
MISS
8/5/2025
04:05 pm
supn
13.1%
BEAT
5/6/2025
04:08 pm
supn
-4.6%
MISS
2/25/2025
04:01 pm
supn
-2.7%
MISS
12/19
09:52 am
Maintains
Hold
Hold
Stifel
Low
2.7%
10/29
08:08 am
Initiates
Buy
Bank of America Corporation
Low
1.1%
9/30
10:12 am
Maintains
Overweight
Overweight
Cantor Fitzgerald
Low
0.0%
12/22
04:04 pm
supn
Low
Form 4 SUPERNUS PHARMACEUTICALS For: Dec 19 Filed by: Mottola Frank
12/19
04:23 pm
supn
Low
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Mottola Frank
12/19
04:06 pm
supn
Low
Form 4 SUPERNUS PHARMACEUTICALS For: Dec 18 Filed by: Bhatt Padmanabh P.
11/24
06:17 pm
supn
Low
Form 4 SUPERNUS PHARMACEUTICALS For: Nov 21 Filed by: NEWHALL CHARLES W III
11/17
08:55 am
supn
Low
Form 4 SUPERNUS PHARMACEUTICALS For: Nov 13 Filed by: Bhatt Padmanabh P.
Show more
Top News Gainers
4/28 Supernus to Acquire CNS Portfolio from US WorldMeds 19.0%
3/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.8%
11/7 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. 6.1%
4/3 Form 8-K SUPERNUS PHARMACEUTICALS For: Mar 30 5.7%
11/8 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. 5.1%
8/27 Form 4 SUPERNUS PHARMACEUTICALS For: Aug 23 Filed by: Khattar Jack A. 5.1%
3/30 Supernus Provides Business Update 4.8%
3/4 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.4%
6/25 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.0%
4/24 Supernus to Host First Quarter Results Earnings Conference Call 3.3%
Top News Decliners
11/5 Q3/2019 9/30/2019 EPS 0.540 ZacksConsensus 0.590 ActVsEst (0.050) - Miss -31.6%
8/6 Q2/2019 6/30/2019 EPS 0.610 ZacksConsensus 0.560 ActVsEst 0.050 - Beat -15.0%
2/25 Supernus Announces Fourth Quarter and Full Year 2019 Financial Results -14.9%
2/26 Why Supernus Pharmaceuticals Plunged 15% Today [The Motley Fool] -7.8%
8/27 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.0%
5/7 Form 8-K SUPERNUS PHARMACEUTICALS For: May 07 -3.5%
5/29 Supernus to Present at the Jefferies 2019 Global Healthcare Conference -3.5%
9/25 Form 8-K SUPERNUS PHARMACEUTICALS For: Sep 25 -3.4%
1/23 Form 8-K SUPERNUS PHARMACEUTICALS For: Jan 21 -2.6%
4/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) had its price target raised by analysts at Piper Sandler from $17.00 to $25.00. They now have a "neutral" rating on the stock. -2.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3